Delta Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 33.82%
- Profit Growth -2063.86%
- Ebitda -1496.03%
- Net Worth -2483.78%
- Total Assets 28.79%
About Delta Bioscience
Delta Bioscience Private Limited (DBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 June 2011 and has a history of 13 years and seven months. Its registered office is in Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sidharth Malhotra, Manish Sharma, Avtar Rai, and One other member serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200CH2011PTC033054
-
Company No.
033054
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Jun 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Delta Bioscience Private Limited offer?
Delta Bioscience Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Common Disease Medicines, Pharmaceutical Medicine, Antiseptic Mouthwashes, Anesthetic, Oral Care Products, Diclofenac, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Delta Bioscience?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avtar Rai
|
Director | 22-Jun-2011 | Current |
|
Sidharth Malhotra
|
Director | 31-Oct-2013 | Current |
|
Manish Sharma
|
Director | 22-Jun-2011 | Current |
|
Divye Malhotra
|
Director | 13-Feb-2017 | Current |
Financial Performance of Delta Bioscience.
Delta Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.82% increase. The company also saw a substantial fall in profitability, with a 2063.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2483.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delta Bioscience?
In 2020, Delta Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bioline Dental Private LimitedSidharth Malhotra, Manish Sharma and 2 more are mutual person
-
Dr. A.S. Thakur Memorial Multispeciality Hospital Private Limited
Divye Malhotra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Delta Bioscience?
Unlock and access historical data on people associated with Delta Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delta Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delta Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
